Implant Sciences sells QS-B220 detector to undisclosed Latin American country

Implant Sciences, a provider of systems and sensors for homeland security and defence markets, has sold its QS-B220 explosives trace detectors to a federal agency in charge of operating 19 airports in one Latin American country.

The QS-B220 units will be deployed at 19 airports for checkpoint screening and air cargo screening.

Implant Sciences sales and marketing vice president Dr. Darryl Jones said the QS-B220, with this deployment, has become the system of choice in explosives trace detection devices for 19 airports.

"The QS-B220 was selected based on its favorable total cost of ownership, superior performance capabilities, and its regulatory certifications," Jones added.

The Quantum Sniffer QS-B220 is a desktop explosive and narcotics trace detector integrated with a high-resolution colour touch-screen that provides audio and visual alarm indications, including substance identification.

Utilising non-radioactive Ion Mobility Spectrometry (IMS) analysis technology, the QS-B220 can quickly detect and identify trace amounts of a range of military, commercial, and homemade explosives, including narcotic substances.

Designed with an automatic internal self-calibration, the detector eliminates issues such as licensing, inspection, transport, and end-of life, while providing freedom from radioactive materials, low total cost of ownership, and high operational availability.